A
Aldeyra Therapeutics (ALDX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Aldeyra Therapeutics (ALDX)
Aldeyra Therapeutics, Inc. is a biotechnology company, which is engaged in developing immune-modulating therapies to treat ocular and systemic diseases. The Company's lead product candidate, reproxalap, is a treatment in late-stage development for dr... Read more
- USD6.90
- USD7.14
- USD6.81
- USD7.20
- 15.90%
- --
- 349.81k
- 633.36k
- 379M
- 2.71
- 132.30%
- 136.90%
Stock News
34 minutes ago
Vital Farms’ stock had its worst-ever month, but analysts say it’s still a buy
MarketWatch
2 hours ago
We're adding to an industrial that eased worries about its AI data center business
CNBC
2 hours ago
What Trump's Department of Education dismantle means for the future of AI in schools
CNBC
3 hours ago
Here are our top and bottom 3 stocks since Trump tariff concerns shook the market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
